LEXEO Therapeutics
PublicLast Round
Follow-on Offering
Oct 20, 2025
Total Funding Raised
$617.4M
Company Overview
Lexeo Therapeutics (NAS: LXEO) is a biotechnology company specializing in clinical-stage genetic medicines aimed at revolutionizing disease treatment through innovative science and targeted gene therapies for hereditary and acquired diseases with high unmet needs.
Sector
Healthcare
AI Layer
Non-AI
Keywords
AAV-based gene therapycardiovascular gene therapyclinical-stage genetic medicinegene therapy for Friedreich's Ataxia cardiomyopathygene therapy for APOE4-associated Alzheimer's diseasesingle-administration gene therapygene therapy for PKP2-Arrhythmogenic Cardiomyopathygene therapy for DSP cardiomyopathyRNA-based cardiac therapeutics
LEXEO Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
LEXEO Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Oct 20, 2025 | ||||
| Private Placement | May 28, 2025 | ||||
| Private Placement | Mar 13, 2024 | ||||
| IPO Announced | Nov 7, 2023 | ||||
| Series B | Sep 9, 2021 | ||||
Series A | Jan 7, 2021 |
LEXEO Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Baird | Follow-on Offering |
| Lundbeck Foundation | Series B, Series A |
| Longitude Capital | Series B, Private Placement, Series A |
| Surveyor Capital | Private Placement |
| Janus Henderson Group | Series B, Series A, Private Placement |
| ADAR1 Capital Management | Private Placement |
| Balyasny Asset Management L.P. | Follow-on Offering |
LEXEO Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersNew York City, New York
Employee Range84
Year Founded2018
Last FundingOct 20, 2025